Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Leonard Moore

Internal Medicine North Hollywood, CA Medical Doctor

NPI 1912296112 CMS profile 987400

5300 Tujunga Ave, Ste 300, North Hollywood, CA 91601

Open in the dashboard

General payments

$16,219

29 records reported · program years 2020–2025

Research payments

$4,200

Paid to them · 1 record reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Leonard Moore of North Hollywood, CA is reported in the CMS Open Payments database as having received $16,219 across 29 general payments and $4,200 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $90 1
2024 General $6,590 12
2023 General $13 1
2022 General $7,336 14
2021 Research $4,200 1
2020 General $2,190 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Leonard Moore
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Leonard Moore were reported at $90. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Leonard Moore Internal Medicine median Middle half National median
2019 $0 $159 $48–$570 $163
2020 $2,190 $119 $33–$402 $114
2021 $0 $135 $37–$521 $132
2022 $7,336 $141 $42–$496 $149
2023 $13 $149 $45–$519 $160
2024 $6,590 $154 $47–$537 $164
2025 $90 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Gilead Sciences, Inc. $16,027 24 payments
  2. ViiV Healthcare Company $121 3 payments
  3. Organon LLC $71 2 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $12,240 3 payments
  2. Travel and Lodging $3,439 9 payments
  3. Food and Beverage $540 17 payments
Products named General payments · program years 2020–2025
  1. Biktarvy $2,190 1 payment
  2. APRETUDE Hiv $90 1 payment
  3. NEXPLANON $44 1 payment
  4. APRETUDE Hiv $30 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2020–2025
  1. Medtronic, Inc. $4,200 1 payment

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$258,368

Of which drugs: $181,521

Medicare patients

1,404

Average age 79

Services billed

3,456

781 women, 623 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Diabetes 48%
Depression 42%
Heart failure 37%
Chronic kidney disease 37%
Alzheimer's or dementia 37%
Ischemic heart disease 36%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Sarscov2 vac 50 mcg/0.5ml im 91322 Office 1,300 1,381 $175,939
Influenza vaccine, trivalent derived from recombinant dna 90673 Office 116 116 $1,933
Vaccine for influenza for administration into muscle, 0.5 ml dosage 90686 Office 115 115 $1,916
Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage 90694 Office 68 68 $1,133
Vaccine for influenza for administration into muscle, 0.5 ml dosage 90656 Office 36 36 $600

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
APRETUDE
  • ViiV Healthcare Company $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

30 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record